FEATURED NEWS

• What the ARCOS Data Won’t Tell You

  July 24, 2019

  Any discussion about ARCOS data must take into account the overall evolution of the prescription opioid epidemic and the complexity of the pharmaceutical supply chain.

• HDA Statement on Release of DEA ARCOS Data

  July 16, 2019

  Healthcare Distribution Alliance (HDA) Senior Vice President of Communications John Parker released the following statement on the release of the Drug Enforcement Administration’s (DEA) Automation of Reports and Consolidated Orders System (ARCOS) data.

• Analysis: Importation Policies Cost-Prohibitive to U.S. Healthcare System, Pose Risks to Patients

  July 15, 2019

  A new report published by the HDA Research Foundation concludes that federal proposals to permit the importation of prescription drugs into the U.S. fail to provide comprehensive guidance and funding to meet current federal safety and quality standards. As highlighted in the report, “The Risks and Realities of Commercial Drug Importation,” implementation of these policies would result in at least $1.1 billion in costs due to patient risks, required federal regulatory oversight and the operational challenges placed on the supply chain.

• Fact Check: Where 60 Minutes Got it Wrong

  June 30, 2019

  60 Minutes has consistently presented misleading, inaccurate accounts of pharmaceutical distributors’ role in the opioid abuse crisis. The latest episode perpetuates a number of myths around the opioid epidemic and does a disservice to any effort to truly understand and address its root causes — notably, the shift in medical practice to treat pain more aggressively and the role of illegal drugs in most overdose deaths.

• HDA Statement on Rhode Island Opioid Fee

  June 15, 2019

  The Healthcare Distribution Alliance (HDA) issued the following statement in response to the Rhode Island Legislature’s inclusion of a $5 million fee on prescription opioids in the state budget.